Tiziana Life Sciences Ltd [TLSA] stock Initiated by B. Riley Securities analyst, price target now $8

Misty Lee

Tiziana Life Sciences Ltd [NASDAQ: TLSA] loss -1.65% on the last trading session, reaching $1.79 price per share at the time.

Tiziana Life Sciences Ltd represents 118.82 million in outstanding shares, while the company has a total market value of $199.51 million with the latest information. TLSA stock price has been found in the range of $1.71 to $1.81.

If compared to the average trading volume of 323.50K shares, TLSA reached a trading volume of 212828 in the most recent trading day, which is why market watchdogs consider the stock to be active.

Here is what top equities market gurus are saying about Tiziana Life Sciences Ltd [TLSA]:

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for TLSA shares is $8.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on TLSA stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

B. Riley Securities have made an estimate for Tiziana Life Sciences Ltd shares, keeping their opinion on the stock as Buy, with their previous recommendation back on December 22, 2020. While these analysts kept the previous recommendation, Laidlaw raised their target price to Buy. The new note on the price target was released on December 17, 2018, representing the official price target for Tiziana Life Sciences Ltd stock.

The Price to Book ratio for the last quarter was 23.12, with the Price to Cash per share for the same quarter was set at 0.07.

Trading performance analysis for TLSA stock

Tiziana Life Sciences Ltd [TLSA] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 5.92. With this latest performance, TLSA shares dropped by -8.21% in over the last four-week period, additionally plugging by 29.71% over the last 6 months – not to mention a rise of 157.11% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for TLSA stock in for the last two-week period is set at 49.39, with the RSI for the last a single of trading hit 0.1384, and the three-weeks RSI is set at 0.1466 for Tiziana Life Sciences Ltd [TLSA]. The present Moving Average for the last 50 days of trading for this stock 1.9016, while it was recorded at 1.7390 for the last single week of trading, and 1.5890 for the last 200 days.

Tiziana Life Sciences Ltd (TLSA) Capital Structure & Debt Analysis

According to recent financial data for Tiziana Life Sciences Ltd. ( TLSA), the Return on Equity (ROE) stands at -232.31%, highlighting a negative impact on investor capital. The Return on Assets (ROA) is -93.18%, reflecting the company’s efficiency in generating profits from its assets. Additionally, Tiziana Life Sciences Ltd’s Return on Invested Capital (ROIC) is -139.58%, showcasing its effectiveness in deploying capital for earnings.

Tiziana Life Sciences Ltd (TLSA) Efficiency & Liquidity Metrics

Based on Tiziana Life Sciences Ltd’s (TLSA) latest financial statements, the Debt-to-Equity Ratio is 0.01%, indicating its reliance on debt financing relative to shareholder equity.

Tiziana Life Sciences Ltd (TLSA) Efficiency & Liquidity Metrics

From an operational efficiency perspective, Tiziana Life Sciences Ltd. (TLSA) effectively leverages its workforce, generating an average of -$1426666.67 per employee. The company’s liquidity position is robust, with a Current Ratio of 1.72% and a Quick Ratio of 1.72%, indicating strong ability to cover short-term liabilities.

An analysis of Institutional ownership at Tiziana Life Sciences Ltd [TLSA]

There are presently around $3.49%, or 6.48%% of TLSA stock, in the hands of institutional investors. The top three institutional holders of TLSA stocks are: GEODE CAPITAL MANAGEMENT, LLC with ownership of 0.22 million shares, which is approximately 0.2162%. HSBC HOLDINGS PLC, holding 0.13 million shares of the stock with an approximate value of $$0.12 million in TLSA stocks shares; and HSBC HOLDINGS PLC, currently with $$0.1 million in TLSA stock with ownership which is approximately 0.1089%.

DBT News
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.